Business Context and Reporting Period
This filing is a Form 13F-HR submitted by Johnson & Johnson (Institutional Investment Manager) for the quarter ended March 31, 2026. The report was signed on May 13, 2026, by Marc Larkins, Secretary. It includes holdings for one other included manager: Johnson & Johnson Innovation - JJDC, Inc.
Key Financial Metrics
As a Form 13F filing, this document reports equity holdings rather than the company's operational financial performance (revenue, profit, cash flow, or debt). The following metrics relate to the reported investment portfolio:
- Total Value of Reported Holdings: $652,355,946
- Total Number of Holdings Entries: 16
- Number of Other Included Managers: 1
Note: The filing text does not provide values for revenue, profit, cash flow, margins, debt, or liquidity for Johnson & Johnson as an operating entity.
Material Changes
The filing text does not provide comparative data for the prior period; therefore, material changes in holdings value or composition cannot be determined from this document alone.
Guidance, Outlook, and Risks
This filing type does not contain management commentary, forward-looking guidance, risk factors, or contingencies regarding the company's business operations. It strictly discloses long-only equity securities held at the end of the reporting period.
Important Facts for Investors to Verify
- Verify the specific 16 equity positions held by Johnson & Johnson and its innovation arm to understand their external investment strategy.
- Confirm the total portfolio value of approximately $652.4 million represents the aggregate value of the reported securities.
- Note that this filing does not reflect Johnson & Johnson's own financial health, stock price, or operational results.